The global Vitamin B2 market exhibited a stable to mildly firm trend during Q2’25, supported by balanced supply-demand fundamentals and consistent downstream consumption. In Asia-Pacific, particularly China, steady procurement from nutraceutical, pharmaceutical, and fortified food sectors, coupled with uninterrupted production and stable availability of fermentation feedstocks such as glucose and yeast, maintained a controlled upward momentum. Export flows remained smooth, reinforcing global supply reliability. In Europe, the market reflected similar firmness, driven by stable imports from Asia, disciplined inventory management, and steady demand from the medical nutrition and supplement industries. Seamless logistics and the absence of freight disruptions further supported market stability. Meanwhile, North America witnessed modest price strengthening, underpinned by consistent pharmaceutical and personal care demand, alongside steady export activity to Europe. Across all regions, suppliers maintained inventory discipline and avoided aggressive stock accumulation, while buyers followed just-in-time procurement strategies. Overall, the market remained well-balanced with limited volatility and a cautiously optimistic outlook.